Inhibrx Biosciences, Inc.
INBX
$14.00
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 799.19% | -- | -- | -- | |
| Total Depreciation and Amortization | 91.86% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -57.85% | -- | -- | -- | |
| Total Other Non-Cash Items | -7,383.32% | -- | -- | -- | |
| Change in Net Operating Assets | 239.14% | -- | -- | -- | |
| Cash from Operations | -0.57% | -- | -- | -- | |
| Capital Expenditure | 43.46% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 43.46% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -64.57% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 100.00% | -- | -- | -- | |
| Cash from Financing | -64.51% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -3,187.66% | -- | -- | -- | |
